- Gene editing developer Scribe plots an IPO<figure><div><img src="https://imgproxy.divecdn.com/sBtYKKH5sscDVuLjDSQCOXakDVLL95AbneXd6jzxisM/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS8yUFA2NlhKLmpwZw==.webp"/></div></f…BioPharma Dive · 21d ago↗ source
- Novartis to acquire ADC developer in a deal worth up to $1.5B<p>The deal hands over two ADCs with a different mechanism of action targeting cell growth, and marks Novartis' entry into ADC development.</p>BioPharma Dive · 21d ago↗ source
- STAT+: Four major biotech updates to catch up onAnthropic CEO talks drug discovery, Medicare proposes steep 340B drug payment cuts, and more biotech newsSTAT · 21d ago↗ source